Oncology
Taking Cancer On
Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on. We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer. Our commitment to innovation has resulted in pioneering treatments for lung cancer and we are advancing a unique pipeline of cancer cell directed agents, immune oncology therapies and intelligent combination approaches to help combat many cancers.
Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right.
-
Human Pharma Pipeline
Pipeline
This represents a selection of assets in our research and development portfolio in June 2020.
-
Oncology
At Boehringer Ingelheim, we believe this can be the generation that redefines many cancers as curable diseases. We want to be part of this transformation.
-
Oncology
For more than 20 years, we are taking cancer on by developing novel therapies with attention to two indication areas: lung cancer and gastrointestinal tumors.